Cancela et al., 1988 - Google Patents
1α, 25 (OH) 2 vitamin D3: A steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanismsCancela et al., 1988
- Document ID
- 16813188981665204384
- Author
- Cancela L
- Nemere I
- Norman A
- Publication year
- Publication venue
- Journal of steroid biochemistry
External Links
Snippet
Vitamin D 3 is now considered a pro-hormone and its biological activities are in a great majority due to its hormonally active derivative 1α, 25-dihydroxyvitamin D 3. The actions of vitamin D 3 have been extensively studied both in vivo and in virto using different animal …
- 108020003175 receptors 0 title abstract description 32
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cancela et al. | 1α, 25 (OH) 2 vitamin D3: A steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanisms | |
| Clément-Lacroix et al. | Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice | |
| Akeno et al. | Regulation of vitamin D-1alpha-hydroxylase and 24-hydroxylase expression by dexamethasone in mouse kidney | |
| Eisman et al. | Intestinal 1, 25-dihydroxyvitamin D3 binding protein: specificity of binding | |
| DeLuca | Vitamin D: metabolism and function | |
| Hedlund et al. | Vitamin D receptor expression is required for growth modulation by 1α, 25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31 | |
| Liel et al. | Evidence that estrogens modulate activity and increase the number of 1, 25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8). | |
| Kato et al. | Studies on 24R, 25-dihydroxyvitamin D3: evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus | |
| Raisz | Hormonal regulation of bone growth and remodelling | |
| Walters et al. | 1, 25-Dihydroxyvitamin D receptors in an established bone cell line. Correlation with biochemical responses. | |
| Hoenderop et al. | Effects of vitamin D compounds on renal and intestinal Ca2+ transport proteins in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice1 | |
| Jung et al. | 1, 25 (OH) 2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia | |
| Catherwood et al. | Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects | |
| Wu et al. | Expression of the renal 25-hydroxyvitamin D-24-hydroxylase gene: regulation by dietary phosphate | |
| Bouillon et al. | Vitamin D resistance | |
| Narbaitz et al. | The role of autoradiographic and immunocytochemical techniques in the clarification of sites of metabolism and action of vitamin D. | |
| Sundell et al. | 1, 25-Dihydroxyvitamin D3 in the Atlantic cod: plasma levels, a plasma binding component, and organ distribution of a high affinity receptor | |
| US7033996B2 (en) | Method for the treatment of vitamin D related disease | |
| Nakagawa et al. | Novel ring A stereoisomers of 2-methyl-1α, 25-dihydroxyvitamin D3 and 2-methyl-20-epi-1α, 25-dihydroxyvitamin D3: transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells | |
| Farach-Carson et al. | 22-Oxacalcitriol: dissection of 1, 25 (OH) 2D3 receptor-mediated and Ca2+ entry-stimulating pathways | |
| Christakos | Vitamin D gene regulation | |
| Fine et al. | Autoradiographic localization of 24R, 25-dihydroxyvitamin D3 in epiphyseal cartilage | |
| Chen et al. | Modulation of intestinal estrogen receptor by ovariectomy, estrogen and growth hormone | |
| Tsugawa et al. | Biological Activity Profiles of 1α, 25-Dihydroxyvitamin D2, D3, D4, D7, and 24-Epi-1α, 25-dihydroxyvitamin D2 | |
| Murray et al. | Variation in 1, 25-dihydroxyvitamin D3 regulation of proliferation and alkaline phosphatase activity in late-passage rat osteoblastic cell lines |